<?xml version="1.0" encoding="UTF-8"?>
<p id="par0060">Once pathogenicity has been established, the efficacy of vaccination must be shown to provide cross-protection against genetically diverse viral ‘field’ strains. In situations where the challenge viruses are highly diverse, the use of multiple viral strains as vaccine antigens may be considered to widen the breadth of cross-protection.</p>
